Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry S Taylor

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Molecular & Cellular Proteomics : MCP|December 14, 2007
Humoral response profiling reveals pathways to prostate cancer progressionBarry S Taylor, Manoj Pal, Jianjun Yu, et al.
Molecular Cancer Therapeutics|November 9, 2014
Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profilingJackie Wanjala, Barry S Taylor, Caren Chapinski, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2010
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective mannerEric W Joseph, Christine A Pratilas, Poulikos I Poulikakos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical SequencingMartee L Hensley, Shweta S Chavan, David B Solit, et al.
Nature Genetics|April 19, 2016
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanomaAmanda R Moore, Emilie Ceraudo, Jessica J Sher, et al.
Cancer Discovery|June 9, 2018
A Secondary Mutation in <i>BRAF</i> Confers Resistance to RAF Inhibition in a <i>BRAF</i><sup>V600E</sup>-Mutant Brain TumorJiawan Wang, Zhan Yao, Philip Jonsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancerLuping Lin, Saurabh Asthana, Elton Chan, et al.
Cancer Research|November 18, 2008
Genetic predictors of MEK dependence in non-small cell lung cancerChristine A Pratilas, Aphrothiti J Hanrahan, Ensar Halilovic, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Copy number alteration burden predicts prostate cancer relapseHaley Hieronymus, Nikolaus Schultz, Anuradha Gopalan, et al.
Blood|August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesisElodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Molecular & Cellular Proteomics : MCP|December 14, 2007
Humoral response profiling reveals pathways to prostate cancer progressionBarry S Taylor, Manoj Pal, Jianjun Yu, et al.
Molecular Cancer Therapeutics|November 9, 2014
Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profilingJackie Wanjala, Barry S Taylor, Caren Chapinski, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2010
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective mannerEric W Joseph, Christine A Pratilas, Poulikos I Poulikakos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical SequencingMartee L Hensley, Shweta S Chavan, David B Solit, et al.
Nature Genetics|April 19, 2016
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanomaAmanda R Moore, Emilie Ceraudo, Jessica J Sher, et al.
Cancer Discovery|June 9, 2018
A Secondary Mutation in <i>BRAF</i> Confers Resistance to RAF Inhibition in a <i>BRAF</i><sup>V600E</sup>-Mutant Brain TumorJiawan Wang, Zhan Yao, Philip Jonsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancerLuping Lin, Saurabh Asthana, Elton Chan, et al.
Cancer Research|November 18, 2008
Genetic predictors of MEK dependence in non-small cell lung cancerChristine A Pratilas, Aphrothiti J Hanrahan, Ensar Halilovic, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2014
Copy number alteration burden predicts prostate cancer relapseHaley Hieronymus, Nikolaus Schultz, Anuradha Gopalan, et al.
Blood|August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesisElodie Pronier, Robert L Bowman, Jihae Ahn, et al.
Pageof 15